La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Altamira Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Altamira Therapeutics..

Altamira Therapeutics (NASDAQ:CYTO) Azioni, Catena delle Opzioni

Altamira Therapeutics

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.

Altamira Therapeutics Ltd. - Common Shares

Altamira Therapeutics Ltd

CytoDyn Inc

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics Ltd

CytoSorbents Corp

Cytokinetics, Incorporated - Common Stock

Cytokinetics Inc

CytomX Therapeutics Inc

CYTOPHAGE TECHS INC by CYTOPHAGE TECHNOLOGIES INC

Cytophage Technologies Ltd

Assured Guaranty (AG)&#x2A; has insured $920 million of senior Special Facilities Revenue Bonds issued by the New York Transportation Development Corporation in connection with the JFK Airport Terminal 6 Redevelopment Project. The insured bonds were issued on November 5 as part of an upsized $1.95 billion offering and included $820 million of Series 2024A (Green Bonds) (AMT) fixed rate, current interest bonds with a maturity in 2054 and approximately $100 million of Series 2024B (AMT) fixed rate convertible capital appreciation bonds with a maturity in 2054.
The bonds were issued to refinance part of JFK Millennium Partners' (JMP) short term 2022A bonds and bank loans that were used to finance its redevelopment project, which will replace former Terminal 6 and 7 with a new world-class, 1.2 million square foot Terminal 6 with sustainable and innovative technology. JMP is a consortium established by Vantage Group, American Triple I, RXR Realty and JetBlue Airways.

News

Financing

Assured Guaranty Insures $920M Of Bonds As Part Of $1.95B JFK Airport Terminal 6 Redevelopment Project

Dividends

MCHP

Microchip Raises Dividend From $0.454 To $0.455

HeartCore Enterprises, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/HTCR#NASDAQ">HTCR</a>) ("HeartCore" or "the Company"), a leading enterprise software and data consulting services company based in Tokyo, announced today that it has received written notice from the Nasdaq Stock Market LLC that the Company demonstrated compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement") and that the Company is therefore in compliance with the Nasdaq Capital Market's listing requirements. As a result, the Company's securities will continue to be listed and traded on The Nasdaq Stock Market.

HTCR

HeartCore Regains Compliance With Nasdaq Listing Requirements

WIIM

EOSE

Eos Energy Enterprises shares are trading lower after the company reported Q3 financial results and cut its FY24 revenue guidance.

Blend (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>), the leading origination platform for digital banking solutions, and Covered Insurance Solutions (Covered), a premier provider of embedded insurance solutions, have announced a new strategic partnership to further streamline the home insurance shopping experience.

BLND

Blend And Covered Insurance Announce New Strategic Partnership To Streamline Home Insurance Shopping

She succeeds Robert Wood, previous Chairman of the Board, who has retired from the board for personal reasons.&nbsp;

Management

MRC Global Names Deborah Adams As Its New Board Chair, Effective Immediately

Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) affirms FY2026 sales outlook from $1.52 billion-1.77 billion to $1.52 billion-1.77 billion.

Guidance

VTOL

Bristow Group Affirms FY2026 Sales Guidance from $1.52B-1.77B to $1.52B-1.77B

Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) affirms FY2025 sales outlook from $1.44 billion-1.61 billion to $1.44 billion-1.61 billion.

Bristow Group Affirms FY2025 Sales Guidance from $1.44B-1.61B to $1.44B-1.61B

CYTK

Cytek Biosciences shares are trading higher following better-than-expected Q3 earnings.

Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) narrows FY2024 sales outlook from $1.35 billion-1.42 billion to $1.35 billion-1.41 billion.

Bristow Group Narrows FY2024 Sales Guidance from $1.35B-1.42B to $1.35B-1.41B

Arteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIP#NASDAQ">AIP</a>) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.12) by 33.33 percent. This is a 33.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $14.71 million which met the analyst consensus estimate. This is a 10.84 percent increase over sales of $13.27 million the same period last year.

Earnings

Earnings Beats

Arteris Q3 Adj $(0.08) Beats $(0.12) Estimate, Sales $14.71M Inline

Safety Insurance Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAFT#NASDAQ">SAFT</a>) reported quarterly earnings of $1.10 per share which missed the analyst consensus estimate of $1.40 by 21.43 percent. This is a 86.44 percent increase over earnings of $0.59 per share from the same period last year. The company reported $295.28 million in sales this quarter. This is a 28.74 percent increase over sales of $229.36 million the same period last year.

Earnings Misses

SAFT

Safety Insurance Group Q3 EPS $1.10 Misses $1.40 Estimate, Sales $295.28M Up From $229.36M YoY

Select Water Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTTR#NYSE">WTTR</a>) reported quarterly earnings of $0.15 per share which met the analyst consensus estimate. The company reported quarterly sales of $371.349 million which beat the analyst consensus estimate of $350.908 million by 5.83 percent. This is a 4.60 percent decrease over sales of $389.273 million the same period last year.

WTTR

Select Water Solutions Q3 2024 GAAP EPS $0.15, Inline, Sales $371.349M Beat $350.908M Estimate

Mayville Engineering (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEC#NYSE">MEC</a>) reported quarterly earnings of $0.21 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $135.392 million which missed the analyst consensus estimate of $157.606 million by 14.09 percent. This is a 14.43 percent decrease over sales of $158.217 million the same period last year.

Mayville Engineering Q3 2024 Adj. EPS $0.21, Inline, Sales $135.392M Miss $157.606M Estimate

LoanDepot shares are trading higher after the company reported better-than-expected Q3 financial results.

Limbach Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMB#NASDAQ">LMB</a>) raises FY2024 sales outlook from $515.00 million-535.00 million to $520.00 million-540.00 million.

Limbach Holdings Raises FY2024 Sales Guidance from $515.00M-535.00M to $520.00M-540.00M  VS Est. 519.25M

UFCS

United Fire Group shares are trading higher after the company reported better-than-expected Q3 financial results.

BBAI

BigBear.ai shares are trading lower after the company reported worse-than-expected Q3 revenue results.

Helios Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLIO#NYSE">HLIO</a>) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.54 by 9.26 percent. This is a 34.09 percent increase over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $194.500 million which missed the analyst consensus estimate of $196.574 million by 1.06 percent. This is a 3.43 percent decrease over sales of $201.400 million the same period last year.

HLIO

Helios Technologies Q3 2024 Adj. EPS $0.59 Beats $0.54 Estimate, Sales $194.500M Miss $196.574M Estimate

2024 ANNUAL GUIDANCE(1)
NOG is reiterating capital expenditure and production guidance and adjusting certain line items. Production taxes are being adjusted to reflect current expectations for the remainder of the year. Natural gas realizations and oil differentials are being adjusted to reflect results experienced year-to-date. Per unit cash G&amp;A is being lowered as the Company has reduced certain external expenses and continues to benefit from increasing production volumes.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Prior Guidance</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Revised Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Annual Production (Boe per day)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">120,000 - 124,000</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">120,000 - 124,000</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Annual Oil Production (Bbls per day)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">73,000 - 76,000</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">73,000 - 76,000</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Capital Expenditures ($ in millions)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$890 - $970</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$890 - $970</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Wells Turned-in-Line ("TIL")</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">93.0 - 98.0</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">93.0 - 98.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Wells Spud</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">73.0 - 78.0</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">73.0 - 78.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Operating Expenses and Differentials:</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Production Expenses (per Boe)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$9.15 - $9.40</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$9.15 - $9.40</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Production Taxes (as a percentage of Oil &amp; Gas Sales)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">9.0% - 9.5%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">8.5% - 9.0%(2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Average Differential to NYMEX WTI (per Bbl)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">($4.00) - ($4.85)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">($4.00) - ($4.50)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Average Realization as a Percentage of NYMEX Henry Hub (per Mcf)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">87.5% - 92.5%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">90.0% - 95.0%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">DD&amp;A Rate (per Boe)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$16.50 - $17.50</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$16.50 - $17.50</td>
</tr>
</tbody>
</table>
</figure>

NOG Reiterates Capital Expenditure And Production Guidance

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news today!



Moving stocks this morning are a merger update, earnings reports, a fraud investigation and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>VS Media (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsme-stock-quote/">VSME</a>) stock is rocketing more than 113% alongside heavy pre-market trading.</li>



<li>SciSparc (NASDAQ:<a href="https://investorplace.com/stock-quotes/sprc-stock-quote/">SPRC</a>) shares are soaring over 89% <a href="https://www.nasdaq.com/press-release/scisparc-updates-regarding-status-automax-merger-2024-08-14">on a merger update</a>.</li>



<li>Altamira Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyto-stock-quote/">CYTO</a>) stock is surging more than 43% with strong early morning trading.</li>



<li>Airship AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/aisp-stock-quote/">AISP</a>) shares are gaining over 26% after releasing its <a href="https://www.nasdaq.com/press-release/airship-ai-reports-second-quarter-2024-financial-results-2024-08-14">Q2 earnings report</a>.</li>



<li>Accuray (NASDAQ:<a href="https://investorplace.com/stock-quotes/aray-stock-quote/">ARAY</a>) stock is increasing more than 23% with its <a href="https://www.nasdaq.com/press-release/accuray-reports-fourth-quarter-and-fiscal-2024-financial-results-2024-08-14">fiscal Q4 earnings</a>.</li>



<li>Lumentum (NASDAQ:<a href="https://investorplace.com/stock-quotes/lite-stock-quote/">LITE</a>) shares are rising over 16% after <a href="https://finance.yahoo.com/news/lumentum-lite-q4-earnings-revenues-211505675.html">beating fiscal Q4 estimates</a>.</li>



<li>Sirius XM (NASDAQ:<a href="https://investorplace.com/stock-quotes/siri-stock-quote/">SIRI</a>) stock is climbing more than 14% without any clear news this morning.</li>



<li>Ulta Beauty (NASDAQ:<a href="https://investorplace.com/stock-quotes/ulta-stock-quote/">ULTA</a>) shares are heading over 14% higher as <a href="https://www.investopedia.com/warren-buffett-berkshire-hathaway-q2-2024-13f-stock-investments-ulta-beauty-heico-apple-8695592">Warren Buffettt buys the stock</a>.</li>



<li>Onconetix (NASDAQ:<a href="https://investorplace.com/stock-quotes/onco-stock-quote/">ONCO</a>) stock is jumping more than 13% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318523992&amp;type=PDF&amp;symbol=ONCO&amp;cdn=bf9be7db95f431594e22ef6ab2dce88a&amp;companyName=Onconetix+Inc.&amp;formType=NT+10-Q&amp;formDescription=Notification+of+inability+to+timely+file+Form+10-Q+or+10-QSB&amp;dateFiled=2024-08-14">alongside preliminary earnings</a>.</li>



<li>Origin Mat (NASDAQ:<a href="https://investorplace.com/stock-quotes/orgn-stock-quote/">ORGN</a>) shares are up over 11% with its <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318523578&amp;type=PDF&amp;symbol=ORGN&amp;cdn=ec1db2e58a1f10bf57b84b9fe1093283&amp;companyName=Origin+Materials+Inc.&amp;formType=10-Q&amp;formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&amp;dateFiled=2024-08-14">latest earnings report</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Turnstone Biologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsbx-stock-quote/">TSBX</a>) stock is plummeting more than 38% after releasing its <a href="https://www.nasdaq.com/press-release/turnstone-biologics-corp-reports-second-quarter-2024-financial-results-and-provides">Q2 earnings report</a>.</li>



<li>Titan Machinery (NASDAQ:<a href="https://investorplace.com/stock-quotes/titn-stock-quote/">TITN</a>) shares are diving over 27% with its <a href="https://www.nasdaq.com/press-release/titan-machinery-inc-announces-preliminary-results-fiscal-second-quarter-ended-july-31">preliminary earnings report</a>.</li>



<li>Jianzhi Education Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/jz-stock-quote/">JZ</a>) stock is tumbling more than 22% on Thursday morning.</li>



<li>Spire Global (NYSE:<a href="https://investorplace.com/stock-quotes/spir-stock-quote/">SPIR</a>) shares are taking an over 21% beating <a href="https://www.globenewswire.com/news-release/2024/08/14/2930592/0/en/Spire-Global-Inc-Investors-Company-Investigated-by-the-Portnoy-Law-Firm.html">on a fraud investigation</a>.</li>



<li>Hempacco (NASDAQ:<a href="https://investorplace.com/stock-quotes/hpco-stock-quote/">HPCO</a>) stock is sliding 20% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318524553&amp;type=PDF&amp;symbol=HPCO&amp;cdn=041c8fee90a6a2a4aab897fbf610d8a1&amp;companyName=Hempacco+Co.+Inc.&amp;formType=NT+10-Q&amp;formDescription=Notification+of+inability+to+timely+file+Form+10-Q+or+10-QSB&amp;dateFiled=2024-08-14">delaying its earnings report</a>.</li>



<li>Vicinity Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/vev-stock-quote/">VEV</a>) shares are dropping more than 18% after applying for a <a href="https://www.nasdaq.com/press-release/vicinity-motor-corp-applies-management-cease-trade-order-2024-08-14">cease trade order</a>.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) stock is decreasing over 17% on <a href="https://finance.yahoo.com/news/faraday-future-announces-reverse-stock-100000210.html">reverse split plans</a>.</li>



<li>Dragonfly Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/dfli-stock-quote/">DFLI</a>) shares are falling more than 16% on <a href="https://finance.yahoo.com/news/dragonfly-energy-holdings-corp-dfli-213503529.html">lackluster Q2 results</a>.</li>



<li>Safe &amp; Green Development (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgd-stock-quote/">SGD</a>) stock is slipping over 14% after <a href="https://www.stocktitan.net/news/SGD/safe-and-green-development-corporation-secures-strategic-investment-0zc93fwswgs0.html">rallying yesterday on investment news</a>.</li>



<li>Avalon Globocare (NASDAQ:<a href="https://investorplace.com/stock-quotes/albt-stock-quote/">ALBT</a>) shares close out our pre-market stock movers down more than 14% <a href="https://investorplace.com/2024/08/why-is-avalon-globocare-albt-stock-up-173-today/">following a rally yesterday</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-aug-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Altamira Therapeutics files mixed shelf offering

Altamira Therapeutics extends distribution agreement with Pharma Nordic

Altamira Therapeutics prices up to $12M public offering

Altamira Therapeutics (CYTO) has released an update. Altamira Therapeutics Ltd. has issued a pre-funded common share purchase warrant, enabling hol...

Altamira Issues Pre-Funded Share Purchase Warrant

Altamira Therapeutics reports 1H results

Altamira Therapeutics (CYTO) has released an update. Altamira Therapeutics has reported a net loss from continuing operations of $4,339,832 for the...

Altamira Therapeutics Reports Narrowed Losses

Altamira Therapeutics Ltd. (CYTO) Q2 2024 Earnings Call Transcript

Altamira Therapeutics receives Nasdaq non-compliance letter

Altamira Therapeutics (CYTO) has released an update. Altamira Therapeutics Ltd. has been notified by Nasdaq of non-compliance with the minimum bid ...

Comments

Altamira Therapeutics

Altamira Therapeutics (CYTO) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO